首页> 外文期刊>The American Surgeon >Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma
【24h】

Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma

机译:肝门部胆管癌手术治疗预后因素的单因素和多因素分析

获取原文
获取原文并翻译 | 示例
           

摘要

Surgery is the only effective treatment able to improve survival of patients with hilar cholangiocarcinoma (CCA). However, the significance of prognostic factors on overall survival is still debated. We evaluated early and long-term outcomes of patients resected for hilar cholangiocarcinoma over a 3-year period to determine the role of prognostic factors and their effect on overall survival. Medical records of patients with hilar CCA who underwent resection between January 2001 and December 2004 were retrospectively reviewed. Univariate and multivariate analysis was performed to identify prognostic factors associated with survival. Thirty-two of 45 patients underwent surgical resection with curative intent. Morbidity was 24.4 per cent; perioperative mortality was 0 per cent. Overall median survival was 22.3 months. Well-differentiated tumor grading and R0 resection were independently associated with better survival at multivariate analysis. Aggressive surgery, including biliary resection combined with major hepatectomy, is a safe procedure with low morbidity and mortality in a tertiary referral hepatobiliary center. The main aim of an aggressive surgical approach is to obtain a microscopic margin-negative resection, which is associated with better prognosis. Another important prognostic factor is tumor grading, which is independently associated with survival. [PUBLICATION ABSTRACT]
机译:外科手术是能够提高肝门胆管癌(CCA)患者生存率的唯一有效治疗方法。但是,关于预后因素对总体生存的意义仍存在争议。我们评估了在三年内因肝门胆管癌切除的患者的早期和长期预后,以确定预后因素的作用及其对总体生存的影响。回顾性地回顾了2001年1月至2004年12月间切除的肝门状CCA患者的病历。进行单因素和多因素分析以鉴定与生存相关的预后因素。 45例患者中有32例进行了根治性手术切除。发病率为24.4%;围手术期死亡率为0%。总体中位生存期为22.3个月。在多变量分析中,高分化的肿瘤分级和R0切除与更好的生存率独立相关。积极的手术,包括胆道切除术和大面积肝切除术,是在三级转诊肝胆中心的低发病率和低死亡率的安全手术。积极的外科手术方法的主要目的是获得镜切缘阴性的切除术,与更好的预后相关。另一个重要的预后因素是肿瘤分级,其与生存独立相关。 [出版物摘要]

著录项

  • 来源
    《The American Surgeon》 |2010年第11期|p.1260-1268|共9页
  • 作者单位

    GIOVANNI RAMACCIATO, M.D.,* GIUSEPPE NIGRI, M.D., Ph.D.,* RICCARDO BELLAGAMBA, M.D.,*NICCOLÒ PETRUCCIANI, M.D.,* MATTEO RAVAIOLI, M.D.,t MATTEO CESCON, M.D.,+MASSIMO DEL GAUDIO, M.D.,+ GIORGIO ERCOLANI, M.D.,+ FABRIZIO DI BENEDETTO, M.D.,+NICOLA CAUTERO, M.D.,+ CRISTIANO QUINTINI, ?.?.,f ALESSANDRO CUCCHETTI, M.D.,+AUGUSTO LAURO, M.D.,+ CHARLES MILLER, M.D.,+. ANTONIO DANIELE PINNA, M.D.+From the *Department of Generai Surgery, Hepato-biliary-pancreatic Unit, University of Rome "La Sapienza,"?G School of Medicine, Sant'Andrea Hospital, Rome, Italy, the [dagger]Liver and Multivisceral Transplantation Unit,University of Bologna, Bologna, Italy, and [double dagger]Liver Transplantation, Cleveland Clinic, Cleveland, OhioAddress correspondence and reprint requests to Giuseppe M.D., Ph.D., Sapienza University of Rome. II School of Medicine, Hepatobiliary Surgery 5EST. St. Andrea Hospital. Via di Grottarossa. 1035-39, 00189 Rome, Italy. E-mail: giuseppe.nigri@uniiOmal.it.,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号